Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts.
Stacchiotti S, Dürr HR, Schaefer IM, Woertler K, Haas R, Trama A, Caraceni A, Bajpai J, Baldi GG, Bernthal N, Blay JY, Boye K, Broto JM, Chen WT, Dei Tos PA, Desai J, Emhofer S, Eriksson M, Gronchi A, Gelderblom H, Hardes J, Hartmann W, Healey J, Italiano A, Jones RL, Kawai A, Leithner A, Loong H, Mascard E, Morosi C, Otten N, Palmerini E, Patel SR, Reichardt P, Rubin B, Rutkowski P, Sangalli C, Schuster K, Seddon BM, Shkodra M, Staals EL, Tap W, van de Rijn M, van Langevelde K, Vanhoenacker FMM, Wagner A, Wiltink L, Stern S, Van de Sande VM, Bauer S.
Cancer Treat Rev. 2023 Jan;112:102491. doi: 10.1016/j.ctrv.2022.102491. Epub 2022 Dec 6.
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.
Cannarile MA, Weisser M, Jacob W, Jegg AM, Ries CH, Rüttinger D.
J Immunother Cancer. 2017 Jul 18;5(1):53. doi: 10.1186/s40425-017-0257-y.
Diffuse-Type Tenosynovial Giant Cell Tumor An Update of Current Management Strategies.
Naja A, Abboud A, Masrouha K, Ghert M, Saghieh S.
Bull Hosp Jt Dis (2013). 2024 Sep;82(3):178-185.
Treatment Modalities for Refractory-Recurrent Tenosynovial Giant Cell Tumor (TGCT): An Update.
Dania V, Stavropoulos NA, Gavriil P, Trikoupis I, Koulouvaris P, Savvidou OD, Mavrogenis AF, Papagelopoulos PJ.
Medicina (Kaunas). 2024 Oct 12;60(10):1675. doi: 10.3390/medicina60101675.
Treatment updates on tenosynovial giant cell tumor.
Palmerini E, Staals EL.
Curr Opin Oncol. 2022 Jul 1;34(4):322-327. doi: 10.1097/CCO.0000000000000853.
Prospects of Treating Tenosynovial Giant Cell Tumor through Pexidartinib: A Review.
Alsayadi YMMA, Chawla PA.
Anticancer Agents Med Chem. 2021;21(12):1510-1519. doi: 10.2174/1871520620999201102123555.
Single-Cell Analysis Clarifies Pathological Heterogeneity in Tenosynovial Giant Cell Tumor and Identifies Biomarkers for Predicting Disease Recurrence.
Xie Y, Chen C, Wu F, Peng Y, Su J, Zhao Y, Huang H, Li ZA, Pei Y, Li W, He Y, Xue T, Cao C, Peng S, Zhang X, Song W.
Adv Sci (Weinh). 2025 Jul;12(26):e2415835. doi: 10.1002/advs.202415835. Epub 2025 Mar 24.
Management of tenosynovial giant cell tumour of the temporomandibular joint: a systematic review.
Kanbour A, Hurrell M, Ricciardo P.
ANZ J Surg. 2023 Apr;93(4):869-875. doi: 10.1111/ans.18186. Epub 2022 Dec 14.
Outcomes of Tenosynovial Giant Cell Tumor of the Foot and Ankle.
Barnett JR, Rudran B, Khan A, O'Reilly-Harbidge S, Patel S, Malhotra K, Cullen N, Welck M, Aston W.
Foot Ankle Int. 2023 Oct;44(10):1013-1020. doi: 10.1177/10711007231189491. Epub 2023 Aug 30.
Diffuse-Type Tenosynovial Giant Cell Tumor: What Are the Important Findings on the Initial and Follow-Up MRI?
Choi WS, Lee SK, Kim JY, Kim Y.
Cancers (Basel). 2024 Jan 17;16(2):402. doi: 10.3390/cancers16020402.
